Colorectal Cancer

Everything

Colon Cancer Screening Could Save Lives In Missouri
www.prlog.org | Mar 11, 2010
Colon Cancer Screening Could Save Lives In Missouri. Colon cancer is deadly but there are ways to prevent cancer and save lives. This article discusses those proven strategies and how you can apply them effectively.

Biomarker Predicts Disease Recurrence in Colorectal Cancer
www.dddmag.com
Findings by researchers at Thomas Jefferson University show that the presence of a biomarker in regional lymph nodes is an independent predictor of disease recurrence in patients with colorectal cancer.

MALDI-TOF MS Combined With Magnetic Beads for Detecting Serum Protein Biomarkers and Establishment
www.medsci.org | Dec 16, 2011
<p>The aim of present study is to study the serum protein fingerprint of patients with colorectal cancer (CRC) and to screen protein molecules that are closely related to colorectal cancer during the onset and progression of the disease with Matrix-assisted laser desorption/ionization

Colorectal Cancer Special Feature Stories and News
www.webmd.com
Find timely health and medical news on Colorectal Cancer at WebMD.

Home | ScheBo® · Biotech AG
www.schebo.com
ScheBo · Biotech AG - Tumor M2-PK Test, M2PK Quick Schnelltest, Brainostic-Test für für BSE-Risikomaterial, Gastroenterologie, Onkologie, Veterinär Diagnostika

Myriad Genetics, Inc. - Myriad Genetics Applauds Major Health Economic Study That Supports Broad
investor.myriad.com
Myriad Genetics, Inc. Logo Print Print page Email Email page PDF Download PDF Add to Briefcase « Previous Release | Next Release » Myriad Genetics Applauds Major Health Economic Study That Supports Broad Application of Genetic Testing for Hereditary Colon Cancer COLARIS is Cost

Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook | SYS-CON MEDIA
www.sys-con.com | May 26, 2011
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

Keryx Biopharmaceuticals Could Easily Triple Within the Next Year -- Seeking Alpha
seekingalpha.com | Apr 11, 2010
<strong>Jeremy Richards submits:</strong><hr><div><div><div><p><b><span>Keryx Biopharmaceuticals</span></b><span></span>(<span>Nasdaq</span>:<a href='http://seekingalpha.com/symbol/kerx' alt='Keryx Biopharmaceuticals Inc.' title='Keryx Biopharmaceuticals Inc.'>KERX</a>)– Should See Double

Medical News: Aspirin as Adjuvant Therapy Improves Colorectal Cancer Survival - in
www.medpagetoday.com | Aug 11, 2009
Aspirin taken regularly after -- but not before -- the diagnosis of colorectal cancer appears to reduce the likelihood of recurrence and the risk of death from colon cancer, at least for those patient

Sanofi-Aventis (France), Regeneron Pharmaceuticals, Inc.: Colon Cancer Treatment Meets Goal In
www.biospace.com | Apr 27, 2011
PARIS and TARRYTOWN, N.Y., April 26, 2011 /PRNewswire/ -- Sanofi-aventis (EURONEXT:SAN - News) and Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN - News) today announced that the Phase III VELOUR trial evaluating the investigational agent ZALTRAP (aflibercept), also known as VEGF Trap, in combination